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Abstract
 
While the specificity and development of natural killer (NK) cells have been intensely studied,
little is known about homeostasis of the mature NK population. Here we show that mouse NK
 
cells undergo homeostatic proliferation when transferred into NK-deficient Rag
 
 
 
/
 
 
 
 
 
 
 
C
 
 
 
/
 
 
 
hosts. Normal NK functional activity is maintained during this process, although there are
some changes in NK phenotype. Using cell sorting, we demonstrate that mature (Mac-1
 
hi
 
) NK
 
cells undergo homeostatic proliferation in an NK-deficient environment, yet immature
 
(Mac-1
 
lo
 
) NK cells also proliferate in such hosts. We find that mature NK cells survive but do
not proliferate in hosts which possess an endogenous NK pool. However, we go on to show
that mature NK survival is critically dependent on interleukin (IL)-15. Surprisingly, NK sur-
vival is also compromised after transfer of cells into IL-15R
 
 
 
 
 
/
 
 
 
 mice, implying that IL-15 re-
sponsiveness by bystander cells is critical for NK maintenance. These data imply that, similar to
T cells, homeostasis of the NK pool is much more dynamic than previously appreciated and
this may be relevant to manipulation of NK cells for therapeutic purposes.
Key words: IL-15 • lymphopenia • cytokines • homeostasis
 
Introduction
 
NK cells are thought to play an important role in immune
defense against pathogens (1–3) and tumors (4–7). The
identity and specificity of both inhibitory and stimulatory
receptors for class I MHC molecules on NK cells has been
intensely studied, and much is known about the role of
these receptors in dictating NK functional activity (8–10).
Other studies have focused on the role of soluble factors in
regulating NK differentiation and function, and this has
lead to identification of IL-15 as a key factor in NK cell
ontogeny. Thus, there is NK deficiency in mice lacking
IL-15 or IL-15 receptor components (comprising of IL-
15R
 
 
 
, IL-2R
 
 
 
, and the common 
 
  
 
chain [
 
 
 
C]
 
*
 
) (11–15).
In contrast to this extensive literature on NK differentia-
tion and effector functions, the factors which influence
maintenance of the mature NK pool have received little
attention. Mature NK cells are typically thought to be a
terminally differentiated population, unable to be main-
tained by self renewal (1, 2, 16). Indeed, NK cells are typi-
cally not in cell cycle, except in response to infection with
certain pathogens or stimulation with high doses of appro-
priate cytokines (such as type I interferons, IL-12 or IL-15;
references 1 and 2). However, it is currently unclear
whether NK cells have a fixed lifespan as nondividing cells
or whether they can respond to homeostatic signals to
maintain the size of the NK pool.
Similar questions have been addressed for the T cell pool,
and it has become clear that mature T cell homeostasis is far
more dynamic than previously suspected (17–20). Survival of
naive mature T cells requires exposure to IL-7 and self-pep-
tide/MHC complexes. Furthermore, naive T cells proliferate
in a T lymphopenic host (a process termed homeostatic pro-
liferation) which, like naive T cell survival, requires exposure
to IL-7 and appropriate self-peptide/MHC complexes. Ho-
meostatic proliferation does not actually replace the naive
pool: naive T cells stably acquire a memory-like phenotype
during homeostatic expansion and thymic output is required
to replenish the naive T cell pool (21, 22). Hence, it has
been speculated that T cells initiate homeostatic proliferation
in an effort to repopulate lymphopenic individuals with
functionally enhanced cells. Indeed, homeostatic prolifera-
tion of T cells can markedly enhance their reactivity to for-
eign antigens and recent work has shown this may be a ther-
apeutic benefit in cancer immunotherapy (23–25).
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Abbreviation used in this paper:
 
 
 
 
 
C, common 
 
 
 
 chain.T
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NK Cell Homeostasis
 
Less is known about survival and homeostatic prolifera-
tion of other lymphocyte subsets. Recent data indicate that
V
 
 
 
14i NK-T cells, like conventional T cells undergo ho-
meostatic proliferation (26). B cell survival requires a func-
tional B cell receptor (27), and exposure to soluble factors
(28). Recent reports suggest that B cells also undergo ho-
meostatic proliferation in B cell-deficient hosts (29), al-
though this may be a property of a subset of B cells (30).
Such findings raise the question of how other mature
lymphoid subsets are maintained. Here we focus on ho-
meostasis of mature NK cells and report that it is a highly
dynamic process. We find that mature NK cells proliferate
rapidly in an NK-deficient environment, arguing that NK
cells are capable of responding to “space” by homeostatic
proliferation. Furthermore, we show that IL-15 is manda-
tory for the survival of mature NK cells, and that this IL-15
dependence is, at least in part, mediated through responses
by other IL-15R
 
 
 
 bearing cells. The implications of these
findings for natural and therapeutic regulation of the NK
pool are discussed.
 
Materials and Methods
 
Mice.
 
Rag-2
 
 
 
/
 
 
 
/
 
 
 
C
 
 
 
/
 
 
 
 double deficient (Rag
 
 
 
/
 
 
 
 
 
C
 
 
 
/
 
 
 
),
CD45.1
 
 
 
 Rag-2
 
 
 
/
 
 
 
 mice (CD45 congenic Rag
 
 
 
/
 
 
 
), and IL-15
 
 
 
/
 
 
 
mice were obtained from Taconic Farms. All of these mice are on
C57BL/6 (B6) or B6/B10 mixed backgrounds. IL-15R
 
 
 
 
 
/
 
 
 
mice were obtained from The Jackson Laboratory. Additional
Rag-2
 
 
 
/
 
 
 
 or Rag-1
 
 
 
/
 
 
 
 mice were obtained from Taconic Farms
or The Jackson Laboratory, respectively. B6 mice and CD45
congenic (CD45.1, also called Ly5.2) B6 mice were obtained
from Jackson Laboratories or the National Cancer Institute. All
mice were maintained under specific pathogen-free conditions
and used at 6–12 wk of age.
 
Adoptive Transfer and Cell Sorting.
 
Red blood cell–depleted
splenocytes were isolated from Rag
 
 
 
/
 
 
 
 mice or B6 mice and la-
beled with CFSE (Molecular Probes) as described previously
(31). In some experiments, Rag
 
   
 
 
 
splenocytes (which were on
average 25% NK1.1
 
 
 
) were used without further purification.
Splenocytes isolated from B6 mice were enriched for NK cells
using SpinSep/Murine NK Cells kit (StemCell Technologies
Inc.) before CFSE labeling and adoptive transfer. In this case the
percentage of NK1.1
 
 
 
 (CD3
 
 
 
)
 
 
 
cells was on average 40%. Be-
tween 0.7 
 
 
 
 10
 
6
 
 and 1.4 
 
 
 
 10
 
6
 
 CFSE-labeled splenocytes were
injected per recipient mouse, unless otherwise indicated. In all
experiments, donor cells were injected intravenously into the
tail vein.
To obtain a pure population of mature Mac-1
 
hi
 
 NK cells, sple-
nocytes from B6 mice were enriched for NK cells by negative se-
lection using MACS microbeads (Miltenyi Biotec). Splenocytes
were labeled with FITC-coupled Abs to B220 (clone RA3–6B2),
I-A
 
b
 
 (AF6–120.1), CD4 (GK1.5), and CD8 (53–6.7) (all from
BD Biosciences). After staining, cells were subject to depletion
using anti-FITC MACS microbeads. This protocol enriched the
NK population by 5–10 fold. Cells in the flow through were then
stained with anti-CD3 FITC (BD Biosciences), anti-Mac1(M1/
70) PE, and NK1.1 (PK136) APC (both from eBioscience) and
further purified using the FACSVantage™ DIVA system. Alter-
natively, splenocytes from Rag
 
 
 
/
 
 
 
 donor mice were directly
stained with anti-CD3, anti-Mac-1, and anti-NK1.1, and sorted
on the FACSVantage™ DIVA. In both cases, cells used for adop-
 
tive transfer experiments were at least 93.5% pure NK1.1
 
 
 
 CD3
 
 
 
and Mac-1
 
hi
 
. Cells were then labeled with CFSE and transferred
into recipient mice as described. 0.7 
 
 
 
 10
 
5
 
 to 2 
 
 
 
 10
 
5
 
 NK1.1
 
 
 
CD3
 
 
 
 Mac1
 
hi
 
 cells were injected.
 
Flow Cytometry.
 
Recipient mice were killed at the time
points indicated and single cell suspensions were prepared from
the spleen. Red blood cell–depleted splenocytes were treated
with 2.4G2.1 (“Fc-Block”) before further staining. Cells were
typically stained with anti-NK1.1 APC, anti-Mac-1 PE (as
above) and anti-CD69 biotin (clone H1.2F3; eBioscience), fol-
lowed by Streptavidin (SA)-PerCP.
For intracellular staining, cells were prepared with the Cyto-
fix/Cytoperm kit in the presence of brefeldin A (BD Biosciences)
and stained with anti-IFN-
 
 
 
 PE (XMG1.2; eBioscience), anti-
NK1.1 APC and Mac-1 biotin followed by SA-PerCP.
Cells were analyzed using a FACSCalibur™ (BD Biosciences)
and analyzed using FLOWJO (TreeStar) software. For the exper-
iment in Fig. 6 b, the rare donor cells were identified and enu-
merated in two ways. In the first approach, total live events were
analyzed for CFSE
 
 
 
 donor cells. In the second method, CFSE
 
 
 
events were acquired from a known starting number of total live
cells. Results from the latter approach are shown, but both meth-
ods yielded similar data.
 
NK Functional Assays.
 
Poly I:C induction of NK function
was performed as described previously (32). Briefly, 150 
 
 
 
g poly
I:C were injected intraperitoneally per mouse. Mice were killed
5.5 h after injection and single cell suspensions prepared from
the spleen. Cytolytic potential of cells was tested in a 
 
51
 
Cr re-
lease assay. Briefly, EL-4 (a syngeneic control target) and YAC-1
(an NK cell target) cells were labeled with 
 
51
 
Cr-sodium chro-
mate for 1 h at 37
 
 
 
C and washed before incubation with the ef-
fector cells. NK cells were recovered from Rag
 
 
 
/
 
 
 
 
 
C
 
 
 
/
 
 
 
 hosts
transferred with Rag
 
 
 
/
 
 
 
 splenocytes 7 d before harvesting, or
from untransferred Rag
 
 
 
/
 
 
 
 mice. NK cells were enriched using
the SpinSep kit (StemCell Technologies Inc.). In these experi-
ments, this protocol yielded a population which was 40–80%
NK1.1
 
 
 
. The number of cells in the effector population was ad-
justed such that the effector to target (E:T) numbers listed reflect
input of NK1.1
 
 
 
 cells. Cells were incubated for 4 h at 37
 
 
 
C and
target cell lysis calculated. Spontaneous release was less than 12%
in the experiment shown. A total of four
 
 
 
51
 
Cr release assays were
performed.
 
Results
 
NK Cells Undergo Homeostatic Proliferation in NK-deficient
Hosts.
 
To study NK cell homeostasis, we used an adop-
tive transfer approach. NK cells were isolated from RAG
 
 
 
/
 
 
 
mice (which lack T and B cells, but possess NK cells) and
were labeled with the dye CFSE before injection into
RAG
 
 
 
/
 
 
 
 
 
 
 
C
 
 
 
/
 
 
 
 mice (which are devoid of all lympho-
cytes). Proliferation of the donor NK pool was observed, as
monitored by dilution of the CFSE dye and increase in
percentage and numbers of donor NK cells over time (Fig.
1 a). If this finding were analogous to T cell homeostatic
proliferation, then donor NK proliferation would depend
on the absence of an endogenous NK pool. To test this, we
transferred NK cells into both Rag
 
 
 
/
 
 
 
 and Rag
 
 
 
/
 
 
 
 
 
 
 
C
 
 
 
/
 
 
 
hosts. Donor cells were distinguished from host NK cells in
the Rag
 
 
 
/
 
 
 
 hosts using an allelic marker. Donor NK cells
proliferated extensively in the Rag
 
   
 
 
 
 
 
C
 
   
 
 
 
hosts, as re-T
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vealed by extensive CFSE dye dilution, but there was min-
imal proliferation of donor NK cells in the Rag
 
   
 
 
 
hosts
(Fig. 1 b). Some CFSE negative cells (
 
 
 
20% on average)
were detected in the congenic donor NK gate after transfer
into Rag
 
   
 
 
 
hosts. These events could be caused by host
(CFSE negative) NK cell contamination in the gate or this
population may represent a small population of rapidly di-
viding donor NK cells (see below). In either case, the bulk
of donor NK cells do not appear to divide in Rag
 
   
 
 re-
cipients. In these experiments we tested the response of
NK cells derived from Rag
 
 
 
/
 
  donors and also NK cells
enriched by negative selection from normal B6 donors. As
shown in Fig. 1 b, both NK populations behaved similarly,
and further experiments were performed using either B6 or
Rag /  animals as a source for NK cells.
In addition to genetic mutation, lymphocyte space can
be induced acutely by irradiation. Indeed, we also found
that NK cells proliferate in sublethally irradiated B6 or
Rag /  hosts, although to a lesser extent than in Rag / 
 C /  hosts (unpublished data). This less vigorous prolifer-
ative response may relate to the fact that NK cells are more
radioresistant than most lymphocytes (33, 34) and thus the
extent of NK-lymphopenia induced by sublethal irradia-
tion may be inadequate.
Thus, our data suggest that NK cells undergo extensive
proliferation in NK cell–deficient recipients, but are main-
tained without cell division in an NK-full host. These data
suggest that NK cells are capable of undergoing homeo-
static expansion in response to NK ‘space’.
Mature and Immature NK Cells Homeostatically Prolifer-
ate. Although the NK development typically occurs in
the bone marrow, some NK precursors are found in the
spleen (32), the source of our NK donor population. This
raised the possibility that we might be studying NK devel-
opment rather than mature NK homeostatic proliferation
in the adoptive transfer model. Recent work from Kim et
al. has elegantly defined the maturation stages of murine
NK cells (32): fully mature NK cells (Stage V cells) express
high levels of the Mac-1 ( M 2) integrin, while their im-
mediate precursors (Stage IV NK cells) are Mac-1lo. This
maturation step is accompanied by acquisition of full NK
functionality. About 90% of the NK cells in the spleen are
Mac-1hi and the remaining 10% are Mac-1lo (32), and this
ratio was typically maintained after homeostatic prolifera-
tion in Rag /  C /  hosts (Fig. 2 a). The proliferating
cells included both Mac-1hi and Mac-1lo subsets, although
the cells with the Mac-1lo phenotype (immature NK cells)
had undergone more rounds of proliferation, as judged by
the extent of CFSE dilution (Fig. 2, b and c).
As Mac-1lo NK cells can give rise to fully mature Mac-
1hi NK cells, it was possible that Mac-1lo cells in our donor
innoculum were solely responsible for the proliferation ob-
served in Rag /  C /  hosts. To test this possibility, we
sorted Mac-1hi NK-1.1  donor NK cells before transfer
into either Rag /  and Rag /  C /  hosts (Fig. 3 a). This
approach revealed that the fully mature Mac-1hi NK subset
was capable of homeostatic proliferation, demonstrated by
extensive proliferation in the NK-deficient Rag /  C / 
hosts but not in the NK-replete Rag /  hosts (Fig. 3 b).
Similar findings were obtained whether the Mac-1hi NK
population was prepared from Rag /  or B6 donor mice
(unpublished data). In addition, we performed preliminary
experiments involving transfer of sorted Mac-1hi donor
NK cells into congenic Rag    hosts. Gating on the do-
nor-derived cells in this case demonstrated that at least 95%
of the donor NK cells were in a single CFSEhi peak at day
5 after transfer, implying no cell division (unpublished
data). This suggests that mature (Mac-1hi /Stage V) NK
cells do not proliferate after transfer into the NK “full”
Rag    host.
Thus, our data with bulk and Mac-1hi purified NK do-
nor populations indicate that both mature and immature
Figure 1. Expansion of NK1.1  cells in an NK-deficient host. (a) Sple-
nocytes were isolated from Rag /  mice, CFSE labeled and transferred
into Rag /  C /  hosts. Hosts and untransferred controls were killed at
days 1 and 13 post transfer and stained for NK1.1 and DX5. (b) Spleno-
cytes were isolated from Rag /  mice (left hand panels) or enriched from
B6 mice (right hand panels). The cells were labeled with CFSE and  1  
106 cells transferred into congenic (CD45.1 ) Rag /  or Rag /  C / 
hosts. After 7 d, the hosts were killed and splenocytes analyzed. The
CFSE profile is shown for cells in the Rag /  hosts (cells gated for
CD45.1 NK1.1  events) in the top panels, and cells in the Rag /  C / 
host (gated on NK1.1  events) in the bottom panels.T
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970 NK Cell Homeostasis
NK populations are capable of homeostatic proliferation in
an NK-deficient host.
NK Cells Maintain Phenotype and Function during Homeo-
static Proliferation. Homeostatic proliferation of naive T
cells results in dramatic changes in phenotype and activity.
In most cases, naive T cells acquire memory markers and
functional properties without transition through a typical
activated stage. On the other hand, some reports indicate
homeostatic proliferation can induce T cell anergy or re-
sult in overt T cell activation (for a review, see reference
20). For these reasons it was of interest to test whether
and how NK phenotype and function were affected by
homeostatic proliferation.
We examined cell surface expression of NK1.1, Mac-1,
and CD69 on donor NK cells after transfer into Rag / 
versus Rag /  C /  hosts. In addition, we monitored the
size of these cells (forward scatter, FSC). For the most part
the phenotype of the cells after homeostatic proliferation
was similar to that of normal mature NK cells. However,
we did observe a consistent rise in FSC (commensurate
with the cells becoming blasts) and elevated expression of
Mac-1 (Fig. 4, a and b). CD69, an early activation marker,
was also elevated on a subset of NK cells undergoing ho-
meostatic proliferation (Fig. 4 c), although this finding was
more variable than the changes in Mac-1 expression.
Lastly, NK1.1 expression was typically unchanged after NK
homeostatic proliferation (Fig. 4 d).
To examine NK cell function, we initially tested whether
homeostatic proliferation influenced the response of NK
cells to poly I:C, a potent inducer of NK activity (probably
via IL-15). Both normal NK cells and NK cells which were
allowed to expand in a Rag /  C /  host were induced
with poly I:C and assayed for IFN-  production (Fig. 5 a)
and up-regulation of CD69 (Fig. 5 b). In addition, we
noted that Mac-1 levels are elevated by poly I:C stimulation
on both populations of NK cells (Fig. 5 c). We also tested
the impact of homeostatic proliferation on the ability of NK
cells to lyse target cells ex vivo. NK cells which had under-
gone homeostatic proliferation in Rag    C    hosts were
able to lyse YAC-1 target cells at least as well as NK cells
derived from Rag    mice (Fig. 5 d). Thus, these func-
tional assays suggest that homeostatic proliferation did not
significantly enhance or diminish NK reactivity.
Figure 2. Both Mac-1lo and Mac-1hi NK cells
proliferate in NK-deficient hosts. Splenocytes from
Rag /  animals were harvested, CFSE labeled, and
adoptively transferred into Rag /  C /  hosts.
Host animals were harvested 7 d post transfer and
stained for NK1.1 and Mac-1. (a) Mac-1 staining in
the NK1.1  population. The CFSE profile for (b)
Mac-1lo (immature phenotype) and (c) Mac-1hi
(mature phenotype) NK cells is shown. The CFSE
level in donor NK cells 7 d after transfer into Rag   
hosts is also shown (open histogram with dotted
line), to indicate the extent of CFSE dilution in the
Rag    C    hosts.
Figure 3. Homeostatic proliferation of mature (Mac-1hi) NK cells. (a)
B6 splenocytes were sorted for NK1.1  CD3  Mac-1hi cells. Purity of the
population before and after sorting is shown. (b) NK1.1  CD3  Mac-1hi
cells were CFSE labeled and transferred into Rag /  and Rag /  C / 
recipients. Hosts were harvested 5 d after transfer. CFSE profile from rep-
resentative Rag /  (gray filled histogram) and Rag /  C /  hosts (un-
filled histogram) are shown.T
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Overall these findings suggest that homeostatic prolifer-
ation had no discernable effect on NK function and a
moderate effect on NK phenotype. Importantly, these
findings also suggested that the proliferation observed in
Rag /  C /  hosts did not arise from activation by en-
dogenous pathogens in these mice: were that to be the
case, we might have expected to see strong expression of
activation markers on the donor NK population from
these hosts (1).
NK Cells Depend on Host IL-15 and IL-15R  Expression
for Survival. As IL-15 plays an important role in NK cell
development and activation (35, 36), we were interested in
Figure 4. NK phenotype after homeostatic ex-
pansion. Splenocytes were harvested from Rag / 
mice, CFSE labeled, and transferred into Rag / 
(gray histograms) and Rag /  C /  (open histo-
grams) hosts. Recipients were killed at day 7 after
transfer. Cells were analyzed for (a) size (forward
scatter), (b) Mac-1, (c) CD69, and (d) NK1.1.
Figure 5. NK cells remain functional after homeo-
static expansion Splenocytes were isolated from
Rag /  mice, CFSE labeled and injected into
Rag /  C /  hosts. 7 d after transfer, these animals
and control Rag /  animals were challenged with
poly (I:C) or left as controls. Spleens of challenged
and unchallenged mice were harvested 5.5 h later.
Splenocytes were stained for (a) IFN- , (b) CD69,
and (c) Mac-1. Poly (I:C) treated animals are repre-
sented in the gray filled profiles, with overlapping
unfilled profiles from untreated controls. Data repre-
sentative from two independent experiments, with
n   3 per condition in each experiment. (d) Spleno-
cytes were harvested from Rag /  animals (open
symbols) and from Rag /  C /  animals which
were transferred with Rag /  NK cells 7 d previ-
ously (filled symbols). NK cells were enriched from the pooled cells of each group and these cells were tested in a 4-h 51Cr-release assay against YAC-1
(squares) versus control EL-4 targets (circles). The percentage of NK1.1  cells in each effector pool was calculated and cell numbers adjusted so that the
E:T ratio reflects input of NK cells into the assay.T
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972 NK Cell Homeostasis
the requirement for IL-15 in NK homeostasis. We en-
riched NK cells from normal B6 donors, labeled them with
CFSE, and transferred the cells into IL-15 /  versus B6
hosts. These host animals are similar in terms of overall
lymphoid cellularity but the IL-15 /  mice are profoundly
NK deficient (15). While donor NK cells persisted well in
the B6 recipients, we saw a striking loss of NK cells in the
IL-15 /  hosts by day 4 after transfer (Fig. 6 a). These find-
ings were unlikely to reflect rejection of the donor cells nor
reduced efficiency of transfer into the IL-15 /  host, since
donor T cells (NK1.1  cells which were contaminants in
the donor input) were present in both hosts (Fig. 6 a). In
the same experiment, both donor NK and T cell popula-
tions proliferated vigorously in Rag /  C /  hosts (Fig. 6
a), demonstrating that these cells were not compromised by
the purification procedures. A small population ( 0.4% of
total splenocytes) of CFSE negative NK1.1  cells was ob-
served in the IL-15    hosts: these cells were present at a
similar frequency to the residual NK population observed
previously in IL-15    mice (15), and we concluded that
these were host-derived cells.
In preliminary experiments, we assayed the time course
for donor NK cell survival after transfer into congenic B6
and IL-15 /  hosts. These data suggested that at 6 h donor
NK cells were present in both types of host, but that the
NK population had already started to decline at 24 h post
adoptive transfer into IL-15 /  hosts (unpublished data).
These data are consistent with a recent report from Cooper
and colleagues, which also suggested a critical role for IL-
15 in mature NK survival (37).
Finally, we studied NK persistence in IL-15R  /  hosts.
One might predict that these hosts would support NK sur-
vival at least as well as B6 controls, as IL-15R  /  mice
express IL-15 but lack endogenous NK cells (14, 35, 38).
Surprisingly, however, donor NK cells decline precipi-
tously in IL-15R  /  recipients, behaving similarly to NK
cells transferred into IL-15 /  hosts (Fig. 6 b). Again, poor
engraftment or rejection of the donor cells is unlikely, as
non-NK cells (identified as being NK1.1 ) in the donor
innoculum were detected at similar numbers in all the host
animals. These data suggest that host expression of both IL-
15 and IL-15R  is necessary for donor NK survival. The
implications of these findings on NK homeostasis are dis-
cussed below
Discussion
This report focuses on homeostasis of the mature NK
population. NK cells (in contrast to T and NK-T cells) de-
velop extrathymically, in the absence of CD3 chains and
RAG proteins (9). NK cells have several characteristics that
partially overlap with those of T cells, including the ability
to mediate target specific lysis and produce IFN-  upon
stimulation.
While the requirements for NK development are being
determined (9, 32), little is known about how the size and
Figure 6. IL-15 is necessary for NK survival. (a) Splenocytes were harvested from B6
donor mice and NK cells enriched. The protocol (Spin-Sep) used significantly increases
the yield of NK cells but a population of (NK1.1 ) donor T cells remains which can be
used as an internal control for transfer in these experiments. After labeling with CFSE,
the cells were transferred into B6, IL-15 / , and Rag /  C /  hosts, as indicated. At
day 4 after transfer, hosts were killed and splenocytes analyzed. The data show the
NK1.1  (red) and NK1.1  (blue) populations. Donor cells are represented in the CFSE 
subset of the B6 and IL-15 /  animals, while many of the donor cells in the
Rag /  C /  hosts are CFSElo. The small population of CFSE negative NK1.1  cells
observed in the IL-15 /  hosts are likely to be host derived cells (see Results). (b) Sple-
nocytes from ten B6 mice were pooled and enriched for NK cells using the SpinSep
protocol. 2   105 CFSE-labeled cells were transferred into each recipient (n   3 for B6,
IL-15 /  and Rag /  C / , n   2 for the IL-15R  / ). Recipients were killed on day
4 after transfer and the spleens were analyzed for the donor (CFSE ) population. Data
are expressed as number of cells (either NK1.1  or NK1.1 ) per million splenocytes, to
correct for variation in splenic size between individual animals in each group. These data
are representative of at least three independent experiments.T
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composition of the mature NK population is maintained.
Here we demonstrate that mature NK cells are not end
stage cells with a fixed lifespan, but that they respond to
endogenous cues which can lead to their proliferation (in
hosts lacking endogenous NK cells), survival (in animals
with a normal NK pool) or loss (in animals lacking IL-15
or IL-15R ).
An important element in interpreting our NK cell trans-
fers was to distinguish between homeostasis versus develop-
ment of NK cells. NK cells develop in the bone marrow
but other tissues, including spleen and liver, also contain
NK precursors (32). A recent report from Yokoyama’s
group has delineated the stages for mouse NK cell develop-
ment, and identified a Mac-1hi population as the final stage
of NK cell development (termed Stage V; reference 32).
By sorting for Stage V (Mac-1hi) NK cells we show that
they are able to survive in NK-replete (Rag / ) hosts and
expand in NK-deficient (Rag /  C / ) hosts, arguing that
this population can enter cell division when exposed to NK
‘space’. In addition, however, experiments in which bulk
NK cells were transferred indicated that a Mac-1lo NK cell
population proliferate extensively in NK-deficient hosts.
Based on previous work, these cells are unlikely to arise
from Stage V mature NK cells and are more likely to be
proliferating Mac-1lo Stage IV NK cells or earlier precur-
sors from the spleen (32). In keeping with this, we ob-
served that the extensively-proliferating, Mac-1lo subset
showed reduced IFN-  production (relative to the Mac-1hi
subset) after poly-I:C induction (unpublished data), a
hallmark of Stage IV NK cells (32). When transferring bulk
NK cells into Rag    hosts, we observed a small popula-
tion of CFSE negative cells, which might represent a small
but rapidly dividing population of donor cells (Fig. 1b). As
we did not observe a similar population after transfer of
Mac-1hi NK cells into Rag    hosts, it seems likely that
such proliferating cells would be derived from Mac-1lo
Stage IV precursors, although we did not directly address
that hypothesis here.
These findings suggest that mature NK cells, like T cells,
are able to undergo homeostatic proliferation in appropri-
ately lymphopenic hosts. In the case of T cells, homeostatic
proliferation is accompanied by conversion of naive T cells
to “memory-like” cells which show the functional and phe-
notypic features of bona fide memory T cells. In our studies
we observe moderate phenotypic changes on NK cells after
homeostatic proliferation, including up-regulation of Mac-1
and slightly elevated expression of CD69, but our data also
indicate that NK function is neither compromised nor en-
hanced by homeostatic proliferation (Fig. 5). This diverges
from the T cell literature where homeostatic proliferation
leads to memory-like functions not observed in the naive
pool (e.g., cytolytic activity by CD8 T cells; references 39
and 40). On the other hand, NK cells are unusual in that
they are constitutively primed for reactivity, as measured by
ex vivo cytolytic activity and rapid IFN-  production upon
induction. In this regard, NK cells perhaps most closely re-
semble preformed memory CD8 T cells, a similarity
strengthened by their shared reliance on IL-15 (41).
T cell homeostatic proliferation has been shown to be
influenced by the TCR, and there is considerable data sug-
gesting that homeostatic proliferation can bias the TCR
repertoire (42). Indeed, it has been suggested that homeo-
static proliferation is a key element in generation of autoag-
gressive T cells in some models of autoimmunity (43). NK
cells also express a variety of MHC class I–specific recep-
tors, some of which inhibit and others activate NK re-
sponses. While we have not yet comprehensively tested
changes in NK receptor repertoire, preliminary data sug-
gest that there are not wholesale alterations in the expres-
sion of several Ly-49 receptors (unpublished data). How-
ever this is clearly an important issue to pursue.
It is interesting to compare these data on NK cells to the
well established requirements for T cell homeostasis (20).
Our data suggest that, like T cells, homeostasis of mature
NK cells depends on cytokines. In the case of T cells, sev-
eral cytokines are able to support naive T cell survival and
homeostatic proliferation in vitro, but compelling data ar-
gue that IL-7 is the obligatory factor in vivo (44–46). Like-
wise, we show here that IL-15 is critical for mature NK
cell survival (Fig. 6). Interestingly, both cytokines also play
a role in development of the respective lymphoid subsets,
IL-7 being required for development of immature T cells
(47, 48) and IL-15 being essential for NK cell development
(14, 15).
In addition to supporting NK development, IL-15 can
induce mature NK proliferation and activation (1, 49). Pre-
vious reports suggested IL-15 could support human NK
survival in vitro (50), but our data extend these findings to
suggest that IL-15 is an obligatory survival cytokine for
murine NK cells in vivo. These findings confirm and ex-
tend a recent report from Caligiuri’s group (37). It has been
shown that IL-15 can act directly on mature NK cells, and
so one might expect that IL-15 also acts directly on mature
NK cells to mediate their survival. However, our data (Fig.
6 b) and those of Ma and colleagues (50a), show that NK
survival is also compromised in IL-15R –deficient hosts.
This is analogous to a previous report showing that IL-15
driven proliferation of normal memory CD8 T cells is
compromised in IL-15R  /  hosts (38). These data argue
that the capacity of IL-15 to mediate survival of both NK
and memory CD8 T cells is critically dependent on IL-
15R  expression by a bystander cell. Interestingly, our data
suggest that this (unknown) cell utilizes an unusual form of
the IL-15 receptor. The standard lymphoid IL-15 receptor
comprises of the IL-15R , IL-2R  and  C chains. Yet in
our studies NK cells transferred into Rag /  C /  hosts
survive (and proliferate) while NK cells transferred into IL-
15R  /  hosts expire (Fig. 6 b; reference 50a). An impli-
cation from these data is that the IL-15 receptor responsible
for NK maintenance contains the IL-15R  chain but not
 C. This might occur if the function of the host cells is to
bind IL-15 (via the high affinity IL-15R  chain) without
a need for cell signaling (via the  C chain). Interestingly, a
very recent report from Dubois et al. support just such a
scheme, with clear demonstration that one cell, expressing
only the  -chain of the IL-15R can efficiently “present”T
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IL-15 to a second cell expressing only the  - and  -chains,
inducing the latter’s proliferation (51). Alternatively, the
discrepancy between support of NK homeostasis in the
Rag /  C /  hosts but not the IL-15R  /  hosts could
concern other cytokines which are impacted by the  C de-
ficiency. In this regard, it is interesting to note that IL-21
has been reported to support NK activation but not NK vi-
ability (52). In IL-15R  /  animals, IL-21 but not IL-15 is
able to act through its receptor, while in Rag /  C /  an-
imals the response to both cytokines is blocked (53). In any
case, a bystander cell seems to be involved in regulating
NK survival. Clearly, further analysis will be needed to de-
fine the mechanism by which IL-15 and its receptor chains
are involved in maintenance of the NK cell pool.
A potential caveat in interpreting these experiments is
that Rag /  C /  and IL-15R  /  hosts differ widely in
lymphoid cellularity, raising the possibility that NK cells
simply fail to find a niche in IL-15 /  and IL-15R  / 
hosts. This seems unlikely when we consider that trans-
ferred NK cells are maintained in B6 hosts, which are sim-
ilar to IL-15 /  and IL-15R  /  hosts in terms of overall
cellularity and which also contain an endogenous NK
population (Fig. 6). Furthermore, preliminary data indi-
cated that NK cells proliferated (albeit moderately) in Flt-
3L /  host mice (unpublished data). These mice have a
partial defect in NK development but are mostly normal
for other splenic lymphoid subsets (54). Thus, NK ho-
meostatic proliferation depends less on the size of the
overall lymphoid compartment than on the size of the NK
pool, analogous to the criteria for T cell homeostatic pro-
liferation (20).
Although the physiological relevance of homeostatic
proliferation in T cells is unclear, this process appears to
occur in clinical settings of lymphopenia (for example as a
result of radio-/chemotherapy or after recovery from
pathogen-induced T cell deficiencies; references 55–58).
Indeed, recent data suggest T cell homeostatic proliferation
can be used to boost tumor immunotherapy (23–25). Like-
wise, our data suggest that NK homeostatic proliferation
can be used to reconstitute a defective NK pool. There is
growing evidence that NK cells can be a critical line of de-
fense against pathogens (2, 3) and cancers (4–7), but that
NK cells may also compromise allogeneic transplants (59).
For these reasons, regulation of NK homeostasis has thera-
peutic potential, and our data suggest strategies of how it
may be manipulated.
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